Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Stern

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Pigment Cell & Melanoma Research|October 4, 2018
Inhibition of isoprenylation synergizes with MAPK blockade to prevent growth in treatment-resistant melanoma, colorectal, and lung cancerNicholas Theodosakis, Casey G Langdon, Goran Micevic, et al.
Molecular Cancer Research : MCR|May 10, 2011
NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53Kathleen A Wilson, Sierra A Colavito, Vincent Schulz, et al.
Cancer Research|November 20, 2002
Active signaling by HER-2/neu in a subpopulation of HER-2/neu-overexpressing ductal carcinoma in situ: clinicopathological correlatesMichael P DiGiovanna, Peiguo Chu, Tracey L Davison, et al.
Nucleic Acids Research|January 12, 2012
Structural mechanism of the phosphorylation-dependent dimerization of the MDC1 forkhead-associated domainJinping Liu, Shukun Luo, Hongchang Zhao, et al.
Breast Cancer Research : BCR|November 21, 2008
ErbB3 is required for ductal morphogenesis in the mouse mammary glandAmy J Jackson-Fisher, Gary Bellinger, Jerrica L Breindel, et al.
Science Signaling|November 5, 2015
Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptakeJonathan W Haskins, Shannon Zhang, Robert E Means, et al.
Breast Cancer Research : BCR|December 18, 2014
Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesisVikram B Wali, Maureen Gilmore-Hebert, Ramanaiah Mamillapalli, et al.
Molecular Cancer Research : MCR|April 28, 2011
Phosphoproteomic screen identifies potential therapeutic targets in melanomaKathryn Tworkoski, Garima Singhal, Sebastian Szpakowski, et al.
Molecular Cancer Therapeutics|May 8, 2015
BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell VolumeNicholas Theodosakis, Matthew A Held, Alexander Marzuka-Alcala, et al.
Cancer Research|November 23, 2016
Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast CancerVikram B Wali, Casey G Langdon, Matthew A Held, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Pigment Cell & Melanoma Research|October 4, 2018
Inhibition of isoprenylation synergizes with MAPK blockade to prevent growth in treatment-resistant melanoma, colorectal, and lung cancerNicholas Theodosakis, Casey G Langdon, Goran Micevic, et al.
Molecular Cancer Research : MCR|May 10, 2011
NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53Kathleen A Wilson, Sierra A Colavito, Vincent Schulz, et al.
Cancer Research|November 20, 2002
Active signaling by HER-2/neu in a subpopulation of HER-2/neu-overexpressing ductal carcinoma in situ: clinicopathological correlatesMichael P DiGiovanna, Peiguo Chu, Tracey L Davison, et al.
Nucleic Acids Research|January 12, 2012
Structural mechanism of the phosphorylation-dependent dimerization of the MDC1 forkhead-associated domainJinping Liu, Shukun Luo, Hongchang Zhao, et al.
Breast Cancer Research : BCR|November 21, 2008
ErbB3 is required for ductal morphogenesis in the mouse mammary glandAmy J Jackson-Fisher, Gary Bellinger, Jerrica L Breindel, et al.
Science Signaling|November 5, 2015
Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptakeJonathan W Haskins, Shannon Zhang, Robert E Means, et al.
Breast Cancer Research : BCR|December 18, 2014
Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesisVikram B Wali, Maureen Gilmore-Hebert, Ramanaiah Mamillapalli, et al.
Molecular Cancer Research : MCR|April 28, 2011
Phosphoproteomic screen identifies potential therapeutic targets in melanomaKathryn Tworkoski, Garima Singhal, Sebastian Szpakowski, et al.
Molecular Cancer Therapeutics|May 8, 2015
BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell VolumeNicholas Theodosakis, Matthew A Held, Alexander Marzuka-Alcala, et al.
Cancer Research|November 23, 2016
Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast CancerVikram B Wali, Casey G Langdon, Matthew A Held, et al.
Pageof 8